Coombs v. Mitchell

District Court, M.D. Florida·Decided September 6, 2024·No. 5:23-cv-00070·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA OCALA DIVISION SILKE COOMBS, Plaintiff, Vv. Case No. 5:23-cev-70-JA-PRL KATHRYN DEVRIES MITCHELL, NICHOLAS MAYABB, and K. RYAN MEEKS, Defendants.

ORDER This case is before the Court on Defendants’ Daubert! motion (Doc. 81 and Plaintiffs response (Doc. 91). Based on the Court’s review of the parties submissions, the motion must be granted in part and denied in part. I, BACKGROUND This dispute stems from the sale of “KM Best Dressed” (KM), an Americar Quarter Horse that Plaintiff, Silke Coombs, purchased from Defendant Kathryr DeVries Mitchell, on April 18, 2022.2 (Doc. 96-15). The parties’ dealings began in December 2021 when Plaintiffs co-agent, Mike Edwards, inquired with Mitchell’s agent, Nicholas Mayabb, about whether KM was for sale. (Doc. 81-2

1 Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). 2 KM is also known as “Amy” and is sometimes referred to as such in deposition testimony and other documents.

at 15:6-18; Doc. 81-5 at 40:5-14, 39:22-40:9). Negotiations between the parties dissipated in the ensuing months but resumed again in March 2022. (See id. at 40:8-13; Doc. 96-9). Around the time the parties resumed negotiations, Mayabb_hirec Defendant K. Ryan Meeks, D.V.M., a veterinarian affiliated with Mitchell anc Mayabb, to perform a flexion test on KM (Doc. 81-5 at 16:1—17:1). KM flexec positive during the test, indicating lameness in one or more legs. (Doc. 91-2 at 33:4-34:8). Based on these findings, Dr. Meeks administered steroid and hyaluronic injections in KM’s coffin bone, stifle, and hock joints on March 28. 2022. Ud. at 36:8-38:21). A few weeks later, the parties negotiated a price for the horse and arranged a pre-purchase examination. (Doc. 96-8 at 35:3—15, 42:6-22). At that time, Mayabb allegedly informed Plaintiffs co-agent, May Edwards, that KM had not received any veterinary treatment since December 2021 or earlier. (Doc. 96-6 at 77:10-80:7). Plaintiff, purportedly unaware of Dr. Meeks’ relationships with Mayabb and Mitchell or his prior treatment of KM, hired Dr. Meeks to perform the pre-purchase examination. (Id. at 44:11-14, 47:1-19). Dr. Meeks did not disclose his prior work for Mayabb or treatment of KM to Plaintiff. (Doc. 96-25 at 104:22-105:6). KM did not exhibit any lameness during the pre-purchase exam, and the parties thereafter concluded the sale of KM for $325,000 and the right of Mitchell to retrieve one embryo from KM. (id. at

42:20—22, 44:17-19; Doc. 36-1). The following month, Plaintiff arranged for KN to be transported from Florida to Arizona, where KM began competing in □□□□□ shows. (Doc. 96-8 at 66:21—25). KM allegedly began exhibiting symptoms of lameness while competing ai a horse show in Monroe, Washington, two months after the sale. (Doc. 89-3 a 56:7-16; Doc. 96-6 at 40:22-24). Plaintiff claims it was only then that she learned KM had flexed positive and received injections in March 2022. (Doc. 89. 5 at 81:22—82:5). KM was ultimately diagnosed with a bone bruise and □□□□□□□□ several months of stall rest to recover. (Doc. 89-5 at 96:6—98:14). Plaintiff claims that KM was sold in a defective condition that Defendants worked to conceal and that the sale would have been different had Plaintiff beer aware of her true condition. (See generally Doc. 1). To support her theory. Plaintiff seeks to introduce the expert testimony of Amy Voliva, D.V.M. and Gary Clay. (Docs. 81-1, 81-7). Defendants now seek to exclude portions of the experts’ testimony under Daubert. II. LEGAL STANDARD Federal Rule of Evidence 702 governs the admissibility of expert opinions and “compels” the Court “to perform [a] critical ‘gatekeeping’ function.” United States v. Frazier, 387 F.3d 1244, 1260 (11th Cir. 2004) (en banc) (quoting Daubert, 509 U.S. 579, 589 n.7, 597 (1998)); see Fed. R. Evid. 702 (“A witness who is qualified as an expert by knowledge, skill, experience, training, or

education may testify in the form of an opinion or otherwise if: (a) the expert’: scientific, technical, or other specialized knowledge will help the trier of fact t¢ understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principle: and methods to the facts of the case.”). To decide the admissibility of an □□□□□□□□ opinions, the Court “engage[s] in a rigorous three-part inquiry” and consider: (1) whether the expert is qualified to provide the opinions, (2) whether “the methodology by which the expert reache[d the opinions] is sufficiently reliable,’ and (3) whether in providing the opinions, the expert will help the □□□□□□□□□□ “understand the evidence or .. . determine a fact in issue.” Frazier, 387 F.3d at 1260 (quoting City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548, 562 (11th Cir. 1998)). “The party offering the expert has the burden of establishing the expert’s qualifications, the methodology’s reliability, and the opinions helpfulness to the factfinder “by a preponderance of the evidence.” Rink v. Cheminova, Inc., 400 F.3d 1286, 1292 (11th Cir. 2005). III. DISCUSSION The Court discusses the testimony of Dr. Voliva and Mr. Clay in turn. A. Dr. Voliva Plaintiff retained Dr. Voliva to opine on several issues in this case, including the fiduciary duties that Dr. Meeks owed to Plaintiff and the scope

and effect of the treatment Dr. Meeks administered to KM. Dr. Voliva wrote it her expert report (Doc. 81-1 at 12-13) that Dr. Meeks breached duties he owe to Plaintiff by failing to disclose his “preexisting financial and professiona relationships with Mayabb and Mitchell” and his recent treatment of KM Moreover, Dr. Voliva interpreted the veterinary records prepared by Dr. Meek: to indicate that KM was experiencing lameness on all four legs such that ther were each injected. Dr. Voliva concluded that the improvement seen in KM a the pre-purchase exam and in the weeks thereafter was a result of the treatmen: administered by Dr. Meeks on March 28, 2022. (Id. at 14-15). Dr. Voliva opine: that the lameness observed in KM beginning in June 2022 was a result of th: effect of the injections subsiding, causing a preexisting injury to be exposed. Defendants argue that much of Dr. Voliva’s report is not based upor sufficient facts and data as required by Daubert and Federal Rule of Evidence 702 and should be excluded. As an initial matter, Defendants point to Dr Voliva’s lack of review of the deposition testimony of Mike Edwards, Mayabb, o1 Mitchell before preparing her report. There is no dispute that Dr. Voliva dic not review this evidence. Nevertheless, Dr. Voliva’s report identifies the records she did review, including Peterson & Smith Equine Hospital veterinary records, the pre-purchase exam report, and Dr. Meeks’ deposition testimony. (Doc. 81-1 at 10). Having reviewed the evidence presented by the parties and Dr. Voliva’s report, the Court is satisfied that Dr. Voliva reviewed and relied on sufficient

Free access — add to your briefcase to read the full text and ask questions with AI

Coombs v. Mitchell, (M.D. Fla. 2024).

Coombs v. Mitchell (Coombs v. Mitchell) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

City of Tuscaloosa v. Harcros Chemicals, Inc.
158 F.3d 548 (Eleventh Circuit, 1998)
United States v. Richard Junior Frazier
387 F.3d 1244 (Eleventh Circuit, 2004)
Rink v. Cheminova, Inc.
400 F.3d 1286 (Eleventh Circuit, 2005)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
United States v. Teresita Sorrels v. NCL (Bahamas), LTD
796 F.3d 1275 (Eleventh Circuit, 2015)
Patricia Wingster v. Frederick Head
318 F. App'x 809 (Eleventh Circuit, 2009)
United States v. Philip Esformes
60 F.4th 621 (Eleventh Circuit, 2023)